Instil Bio, Inc. Short-term Lease, Cost
Instil Bio, Inc. (TIL) reported Short-term Lease, Cost of $375.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ShortTermLeaseCost · last filed 2024-03-21
- Instil Bio, Inc. short-term lease, cost for the quarter ending 2022-12-31 was $284.00K.
- Instil Bio, Inc. short-term lease, cost for the quarter ending 2022-09-30 was $521.00K.
- Instil Bio, Inc. short-term lease, cost for the quarter ending 2022-06-30 was $183.00K.
- Instil Bio, Inc. short-term lease, cost for the quarter ending 2022-03-31 was $167.00K.
- Instil Bio, Inc. short-term lease, cost for fiscal 2023 was $375.00K, a 67.53% decline from fiscal 2022.
- Instil Bio, Inc. short-term lease, cost for fiscal 2022 was $1.16M.
| Period end | Short-term Lease, Cost 3 month | Short-term Lease, Cost 6 month | Short-term Lease, Cost 9 month | Short-term Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-12-31 | $375.00K 10-K · filed 2024-03-21 | |||
| 2022-12-31 | $284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $805.00K derived: sum of 2 quarters · filed 2024-03-21 | $988.00K derived: sum of 3 quarters · filed 2024-03-21 | $1.16M 10-K · filed 2024-03-21 |
| 2022-09-30 | $521.00K 10-Q · filed 2022-11-14 | $704.00K derived: sum of 2 quarters · filed 2022-11-14 | $871.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $183.00K 10-Q · filed 2022-08-12 | $350.00K 10-Q · filed 2022-08-12 | ||
| 2022-03-31 | $167.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |